<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00925041</url>
  </required_header>
  <id_info>
    <org_study_id>Avedro T1</org_study_id>
    <nct_id>NCT00925041</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of the Vedera KXS for the Treatment of Spherical Myopia</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Avedro, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Avedro, Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this clinical investigation is to evaluate the safety and efficacy of the
      Vedera KXS in sighted eyes for the correction of spherical myopia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>UCVA 20/40 or better</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Kxl Vedera</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vedera KXS</intervention_name>
    <description>one treatment with the Vedera KXS</description>
    <arm_group_label>Kxl Vedera</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must be undergoing surgery for the correction of myopia

          -  Intended treatment from -0.5 to -6.0 D of spherical myopia

          -  Must have 0.50 D or less astigmatic component.

          -  Must have bilateral physiologic myopia

          -  BSCVA of 20/25 or better in each eye

          -  Must have had a stable refraction (0.5 D or less change in spheroequivalent) for at
             least one year, objectively documented (by previous clinical records, eyeglass
             prescriptions, etc. over one year old)

          -  Patients who are contact lens wearers must have hard or gas permeable lenses
             discontinued for two weeks and soft lenses discontinued for three days prior to the
             preoperative evaluation

          -  Must be at least 18 years of age

          -  Corneal topography must be normal, as judged by the investigator

          -  Must have a minimal corneal thickness of 475 microns

          -  Must sign a written Informed Consent form acknowledging their awareness of their
             participation in this study, the alternative treatments available, the risks involved,
             and the investigative nature of the procedure, and other issues which conform to the
             standard of care for Informed Consent practices

          -  Must be willing and capable of returning for scheduled follow-up examinations for 24
             months after treatment

        Exclusion Criteria:

          -  Patients who are unable or unwilling to sign the informed consent form.

          -  Anterior segment pathology

          -  Residual, recurrent or active ocular disease

          -  Patients who have undergone previous intraocular or corneal surgery involving the
             stroma in the eye to be operated.

          -  History of herpes keratitis

          -  Patients with diagnosed autoimmune disease, systemic connective tissue diseases or
             atopic syndrome, diabetes mellitus, or taking systemic medications (i.e.,
             corticosteroids or antimetabolites) likely to affect wound healing.

          -  Irregular central keratometry/topography readings with irregular topography patterns
             or keratometry mires, including signs of keratoconus.

          -  Patients with known sensitivity to study medications.

          -  Intraocular pressure of &gt; 23 mm Hg by Goldmann applanation tonometry, a history of
             glaucoma, or glaucoma suspect.

          -  Women who are pregnant or nursing or who plan to become pregnant over the course of
             their participation in this investigation.

          -  Participation in other ophthalmic clinical trials during this clinical investigation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Beyoglu Eye Research and Education Hospital</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>June 18, 2009</study_first_submitted>
  <study_first_submitted_qc>June 18, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2009</study_first_posted>
  <last_update_submitted>January 8, 2019</last_update_submitted>
  <last_update_submitted_qc>January 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

